THERAPEUTIC AREA PORTFOLIO · 24 PRODUCTS
Immunology & Inflammation
免疫与炎症
Catalog programs in this area include JAK and TYK2 pathway modulators, immune-mediated dermatology candidates, inflammatory-disease programs and other targeted approaches to immune regulation.
Target APIs & Active Pipeline Programs in Immunology & Inflammation
LcotrokinraTofacitinibBelumosudilAbrocitinibRuxolitinibBrensocatibUpadacitinibBaricitinibBrepocitinibDeucravacitinib
Immunology & Inflammation Products (24)
Catalog products related to terminal APIs in this area.
E-08CAS 1029716-44-6
1-(1-Ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazoleTarget API: Baricitinib / Ruxolitinib
E-09CAS 941685-26-3
4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-D] pyrimidineTarget API: Baricitinib / Tofacitinib
E-12CAS 2121561-39-3
N-isopropyl-2-(3-(4-oxo-3,4-dihydroquinazolin-2-yl)phenoxy)acetamideTarget API: Belumosudil
E-34CAS 1062580-52-2
(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochlorideTarget API: Tofacitinib
E-38CAS 477600-74-1
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amineTarget API: Tofacitinib
E-39CAS 1428243-26-8
(3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidine carboxylic acid phenylmethyl esterTarget API: Upadacitinib
E-40CAS 1201187-44-1
tert-butyl 5-tosyl-5H-pyrrolo[2,3-b]pyrazin-2-ylcarbamateTarget API: Upadacitinib
E-41CAS 1273567-44-4
(S)-4-(tert-butoxycarbonyl)-1,4-oxazepane-2-carboxylic acidTarget API: Brensocatib